Skip to main content
. 2023 Jun 3;23:148. doi: 10.1186/s12893-023-02056-w

Table 3.

Comparison of clinical variables before and after intervention between groups

Variables Group Before intervention After intervention Delta* P-value
SBP (Mean, SD) Control 110.84 (17.52) 111.84 (24.19) 1 (28.85) 0.36
Case 114.83(11.07) 124.58 (17.69) 9.75 (16.57)
DBP (Mean, SD) Control 67.84 (14.77) 66.07 (9.97) -1.77 (14.69) 0.45
Case 70.75 (6.35) 74.16 (17.98) 3.41 (19.32)
HR (Median, IQR) Control 82 (75–112) 90 (75–100) 2 (-6–9) 0.82
Case 99 (75 − 11) 89 (79–109) 1(-19–14.5)
RR (Median, IQR) Control 20 (16–20) 16 (14–20) 0 (-5–4) 0.54
Case 18 (17–21) 19 (16–21) -2 (-2–0.5)
SI (Mean, SD) Control 0.88 (0.48) 0.80 (0.17) -0.08 (0.44) 0.96
Case 0.83 (0.20) 0.76 (0.26) -0.07 (0.22)
MAP (Mean, SD) Control 82.17 (14.46) 81.33 (12.95) -0.84 (15.89) 0.35
Case 85.44 (7.27) 90.97 (17.16) 5.53 (17.65)
PaO2/FIO2 (Mean, SD) Control 304.90 (137.97) 300.57 (143.84) -4.33 (217.60) 0.019 a
Case 198.45 (111.79) 394.50 (149.67) 196.04 (173.27)
NLR (Median, IQR) Control 5.64 (3.72–11.99) 4.90 (4.20–6.10) -1.28 (-5.18–0.48) 0.88
Case 11.16 (6.24–17.67) 7.39 (3.23–15.48) -3.64 (-6.28–2.56)

SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; HR, Heart Rate; RR, Respiratory Rate; SI, Shock Index; MAP; Mean Arterial Pressure; NLR, neutrophil to Lymphocyte Ration; SD, Standard Deviation; IQR, Inter-Quartile Range; NLR, Neutrophil/Lymphocyte Ratio

* The changes between the values of before and after intervention

a Statistically Significant